LAVAL, Quebec, Dec. 15, 2017 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (“Valeant”) announced today the results to date of the pending cash tender offers (the “Tender Offers”) by Valeant and Valeant Pharmaceuticals International (“VPI,” and together…